Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Petter Mathias Bjornstad

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS
Phone720/777-4659

    Collapse Biography 
    Collapse awards and honors
    2013Travel Award to Gothenburg, Sweden, ISPAD
    20141st Place Award at Pediatric Spring Research Poster Session, University of Colorado School of Medicine
    2014Travel Award to Toronto, Canada, ISPAD
    2015Outstanding Research by a Resident, University of Colorado School of Medicine
    2015Curing Chronic Kidney Disease Course and Travel Stipend, ASN
    2016Pediatric Endocrine Society Travel Award, PES
    2016Clinical Research Award for Fellows, Society of Pediatric Research (SPR)
    2017Abstract Awards in Type 1 Diabetes, Helmsley Charitable Trust
    2017Best Research Presentation at ISPAD Science School, ISPAD
    2017Young Investigator Award , ISPAD
    2017Young Investigator Award, Endocrine Society
    2019Diabetes Care Distinguished Reviewer Award , American Diabetes Association
    2019Best Communication Prize for A Clinical Study, European Diabetic Nephropathy Study Group
    2020Presidents' Select Abstracts , American Diabetes Association
    2020Young Physician Scientist Award , The American Society of Clinical Investigation (ASCI)
    2021Dr. Robert Goldstein Award, JDRF

    Collapse Overview 
    Collapse overview
    PLOS ONE Academic Editor
    Diabetes Care Editorial Board
    Pediatric Diabetes Editorial Board
    Journal of Diabetes and its Complications Editorial Board
    Q Magazine Editorial Board
    ASN Diabetic Kidney Disease Collaborative (DKD-C) Workgroup
    ADA Diabetic Kidney Disease Workgroup
    ADA Precision Medicine Workgroup

    Collapse Research 
    Collapse research activities and funding
    3-SRA-2022-1243-M-B     (KENDRICK, JESSICA; FURGESON, SETH; BJORNSTAD, PETTER M)Aug 1, 2022 - Jul 31, 2025
    JDRF
    Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
    Role: Multiple Principal Investigator
    R01 DK132399     (BJORNSTAD, PETTER M; DE BOER, IAN)May 23, 2022 - Mar 31, 2027
    NIH/NIDDK
    Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort
    Role: Multiple Principal Investigator
    3-SRA-2022-1097-M-B     (BJORNSTAD, PETTER M)Jan 1, 2022 - Dec 31, 2025
    JDRF
    Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics
    Role: Principal Investigator
    UM1 DK072493 (Subaward)     (BJORNSTAD, PETTER M)Oct 1, 2021 - Sep 30, 2022
    NIH/NIDDK
    Subaward of Teen Longitudinal Assessment of Bariatric Surgery
    Role: Principal Investigator
    R01DK129211     (BJORNSTAD, PETTER M)Aug 27, 2021 - Jun 30, 2026
    NIH
    Puberty, diabetes, and the kidneys, when eustress becomes distress
    Role: Principal Investigator
    R21DK129720     (BJORNSTAD, PETTER M)Aug 1, 2021 - Jul 31, 2022
    NIH
    Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney disease
    Role: Multiple Principal Investigator
    R01 DK130266     (CHONCHOL, MICHEL; NOWAK KRISTEN)Jul 1, 2021 - Jun 30, 2026
    NIH/NIDDK
    Inspiratory Muscle Strength Training for Lowering Blood Pressure in Midlife and Older Adults with Chronic Kidney.
    Role: Co-investigator
    Industry-initiated Study     (BJORNSTAD, PETTER M)Jul 1, 2021 - Jun 30, 2023
    Novo Nordisk
    REMODEL: Renal mode of action of semaglutide in patients with type 2 diabetes and chronic kidney disease
    Role: Site Principal Investigator and Steering Committee Member
    U01 DK61242 (Subaward)     (BJORNSTAD, PETTER M)May 1, 2021 - Aug 31, 2022
    NIH/NIDDK
    TODAY2 Metabolomics and Proteomics Core
    Role: Principal Investigator
    Investigator Initiated Study     (HEERSPINK, HIDDO)Mar 1, 2021 - Feb 28, 2023
    Astra Zeneca
    DAPASALT: An Open Label, Phase IV, Mechanistic, Study to Evaluate the Natriuretic Effect of 2-Week Dapagliflozin treatment in Type 2 Diabetes Mellitus Patients with Impaired Renal Function
    Role: Site Principal Investigator
    20IPA35260142     (BJORNSTAD, PETTER M)Jan 1, 2021 - Dec 31, 2022
    American Heart Association
    The Effects of Bariatric Surgery on the Cardio-Renal Axis in Youth-onset Type 2 Diabetes
    Role: Principal Investigator
    Webb-Waring Biomedical Research Award     (BJORNSTAD, PETTER M)Jul 1, 2020 - Jun 30, 2023
    Boettcher Foundation
    Role: Principal Investigator
    U2C DK114886 (Subaward)     (BJORNSTAD, PETTER M)Jul 1, 2020 - Jun 30, 2022
    NIH/NIDDK
    Kidney Physiology Phenotyping in the Kidney Precision Medicine Project
    Role: Principal Investigator
    Investigator Initiated Study     (BJORNSTAD, PETTER M)Jun 1, 2020 - May 31, 2023
    Horizon Pharma
    ULTRA-T2D Study: Uric acid lowering trial in youth onset T2D
    Role: Principal Investigator
    P30 DK116073 (Pilot and Feasibility Award)     (BJORNSTAD, PETTER M)Apr 1, 2020 - Mar 31, 2022
    NIH/NIDDK
    Spatial metabolomics for human kidney interrogation of early diabetic kidney disease.
    Role: Principal Investigator
    CU-PKD Pilot Award     (BJORNSTAD, PETTER M)Feb 1, 2020 - Jan 31, 2023
    CU-PKD (Internal)
    Hyena Study: Hemodynamic and Energetic in ADPKD
    Role: Principal Investigator
    2-SRA-2019-845-S-B     (BJORNSTAD, PETTER M)Dec 1, 2019 - May 30, 2022
    JDRF
    CROCODILE Study: Control of Renal Oxygen COnsumption, mitochondrial Dysfunction and InsuLin rEsistance
    Role: Principal Investigator
    Collaborative Research Agreement     (BJORNSTAD, PETTER M)Jul 1, 2019 - Jun 30, 2020
    Johns Hopkins University
    Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
    Role: Principal Investigator
    Novel Method Development Award     (BJORNSTAD, PETTER M)May 1, 2019 - Apr 30, 2020
    CCTSI
    COMFORT Study: Phase-Contrast MRI to Calculate Glomerular Filtration Rate Study
    Role: Principal Investigator
    DiaComp 18AU3871     (BJORNSTAD, PETTER M)Nov 1, 2018 - Oct 31, 2019
    NIH/NIDDK
    Define Renal Oxygenation Levels and Perfusion in Hyperfiltration in Adolescents with Type 1 Diabetes.
    Role: Principal Investigator
    U2C DK114886 (Subaward)     (BJORNSTAD, PETTER M)Sep 1, 2018 - Apr 3, 2023
    NIH/NIDDK
    Tissue based integrative biology of early diabetic kidney disease in youth-onset type 2 diabetes
    Role: Principal Investigator
    2-SRA-2018-627-M-B     (BJORNSTAD, PETTER M)Sep 1, 2018 - Aug 31, 2020
    JDRF
    Vasopressin activity and intrarenal hemodynamic function in early and advanced diabetic kidney disease
    Role: Principal Investigator
    K23DK116720     (BJORNSTAD, PETTER M)Jul 1, 2018 - Apr 30, 2023
    NIH
    Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
    Role: Principal Investigator
    CO-M-18-65     (BJORNSTAD, PETTER M)Jul 1, 2018 - Jun 30, 2019
    CCTSI CO-Pilot Award
    Impact of Bariatric Surgery on intrarenal hemodynamic function in obese adolescents with type 2 diabetes.
    Role: Principal Investigator
    Seed Grant     (BJORNSTAD, PETTER M)Oct 1, 2017 - Sep 30, 2018
    Center for Women’s Health Research (CWHR)
    Sex-related Differences in Vasopressin, Renin-Angiotensin-Aldosterone System and Intrarenal Hemodynamic Function in Adults with Longstanding Type 1 Diabetes
    Role: Principal Investigator
    JDRF-ISPAD Fellowship Award     (BJORNSTAD, PETTER M)Jul 1, 2017 - Jul 1, 2019
    JDRF and ISPAD
    Diabetic Kidney Alarm Study – Tubulopathy in New Onset Diabetic Ketoacidosis
    Role: Principal Investigator
    3-SRA-2017-424-M-B     (KRETZLER, MATTHIAS)Jun 1, 2017 - Oct 31, 2021
    JDRF
    Tissue based integrative biology of diabetic nephropathy in participants of the PERL-study
    Role: Site Principal Investigator
    Early Career Award     (BJORNSTAD, PETTER M)Jan 31, 2017 - Jun 30, 2019
    Thrasher Research Fund
    Tubular dysfunction in diabetic ketoacidosis
    Role: Principal Investigator
    T32 DK063687     (SLOVER, ROBERT)Jul 16, 2016 - Jun 30, 2018
    NIH/NIDDK
    Developing Pediatric Endocrinologist for the Future
    Role: Fellow
    Pilot Funds     (BJORNSTAD, PETTER M)Jul 1, 2016 - Jun 30, 2018
    Diabetes Foundation Guild
    Determine the effects of diabetic ketoacidosis on tubular injury biomarkers
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sawyer A, Zeitler E, Trachtman H, Bjornstad P. Kidney Considerations in Pediatric Obesity. Curr Obes Rep. 2023 Sep; 12(3):332-344. PMID: 37558892.
      View in: PubMed
    2. Tommerdahl KL, Kula AJ, Bjornstad P. Pharmacological management of youth with type 2 diabetes and diabetic kidney disease: a comprehensive review of current treatments and future directions. Expert Opin Pharmacother. 2023 Jun; 24(8):913-924. PMID: 37071054.
      View in: PubMed
    3. Pauley ME, Vinovskis C, MacDonald A, Baca M, Pyle L, Wadwa RP, Fornoni A, Nadeau KJ, Pavkov M, Nelson RG, Gordin D, de Boer IH, Tommerdahl KL, Bjornstad P. Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes. J Diabetes Complications. 2023 02; 37(2):108384. PMID: 36623423.
      View in: PubMed
    4. Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS, Wadwa RP, Zabeen B, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec; 23(8):1432-1450. PMID: 36537531.
      View in: PubMed
    5. Tommerdahl KL, Kendrick J, Nelson RG, Bjornstad P. Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms. Clin Sci (Lond). 2022 11 11; 136(21):1471-1483. PMID: 36326718.
      View in: PubMed
    6. Tommerdahl KL, Bjornstad P, Rebholz CM, Parikh CR. Response to Letter to the Editor Entitled "The Missing Link Between Coffee Consumption and AKI - Water". Kidney Int Rep. 2022 Nov; 7(11):2549. PMID: 36531892.
      View in: PubMed
    7. Sen T, Scholtes R, Greasley PJ, Cherney DZI, Dekkers CCJ, Vervloet M, Danser AHJ, Barbour SJ, Karlsson C, Hammarstedt A, Li Q, Laverman GD, Bjornstad P, van Raalte DH, Heerspink HJL. Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND. Diabetes Obes Metab. 2022 08; 24(8):1578-1587. PMID: 35478433.
      View in: PubMed
    8. Tommerdahl KL, Hu EA, Selvin E, Steffen LM, Coresh J, Grams ME, Bjornstad P, Rebholz CM, Parikh CR. Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From?the Atherosclerosis Risk in Communities Study. Kidney Int Rep. 2022 Jul; 7(7):1665-1672. PMID: 35812301.
      View in: PubMed
    9. Tommerdahl KL, Vinovskis C, Li LP, Rebholz CM, Severn C, Hu EA, Selvin E, Coresh J, Grams ME, Prasad P, Parikh CR, Bjornstad P. The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics. Kidney Int Rep. 2022 Jul; 7(7):1682-1685. PMID: 35812290.
      View in: PubMed
    10. Vigers T, Vinovskis C, Li LP, Prasad P, Heerspink H, D'Alessandro A, Reisz JA, Piani F, Cherney DZ, van Raalte DH, Nadeau KJ, Pavkov ME, Nelson RG, Pyle L, Bjornstad P. Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes. Pediatr Nephrol. 2023 01; 38(1):193-202. PMID: 35507146.
      View in: PubMed
    11. Melena I, Piani F, Tommerdahl KL, Severn C, Chung LT, MacDonald A, Vinovskis C, Cherney D, Pyle L, Roncal-Jimenez CA, Lanaspa MA, Rewers A, van Raalte DH, Cara-Fuentes G, Parikh CR, Nelson RG, Pavkov ME, Nadeau KJ, Johnson RJ, Bjornstad P. Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study. J Diabetes Complications. 2022 06; 36(6):108203. PMID: 35523653.
      View in: PubMed
    12. Gordin D, Bjornstad P, van Raalte DH. Lipids in CKD: What do we actually know? Atherosclerosis. 2022 06; 350:97-99. PMID: 35469655.
      View in: PubMed
    13. Tommerdahl KL, Kendrick J, Bjornstad P. The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial. Clin J Am Soc Nephrol. 2022 06; 17(6):905-907. PMID: 35396319.
      View in: PubMed
    14. Tommerdahl KL, Nelson RG, Bjornstad P. Dapagliflozin in young people with type 2 diabetes. Lancet Diabetes Endocrinol. 2022 05; 10(5):303-304. PMID: 35378070.
      View in: PubMed
    15. Suijk DLS, van Baar MJB, van Bommel EJM, Iqbal Z, Krebber MM, Vallon V, Touw D, Hoorn EJ, Nieuwdorp M, Kramer MMH, Joles JA, Bjornstad P, van Raalte DH. SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function. Clin J Am Soc Nephrol. 2022 05; 17(5):663-671. PMID: 35322793.
      View in: PubMed
    16. Menon R, Bomback AS, Lake BB, Stutzke C, Grewenow SM, Menez S, D'Agati VD, Jain S. Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation. Kidney Int. 2022 06; 101(6):1116-1125. PMID: 35339536.
      View in: PubMed
    17. Johnson MJ, Tommerdahl KL, Vinovskis C, Waikar S, Reinicke T, Parikh CR, Obeid W, Nelson RG, van Raalte DH, Pyle L, Nadeau KJ, Bjornstad P. Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes. Pediatr Nephrol. 2022 12; 37(12):3085-3092. PMID: 35286453.
      View in: PubMed
    18. Looker HC, Pyle L, Vigers T, Severn C, Saulnier PJ, Najafian B, Mauer M, Nelson RG, Bjornstad P. Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes. Diabetes Care. 2022 02 01; 45(2):436-443. PMID: 35006272.
      View in: PubMed
    19. Hesp AC, Smits MM, van Bommel EJM, Muskiet MHA, Tonneijck L, Nieuwdorp M, Kramer MHH, Joles JA, Bjornstad P, van Raalte DH. Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials. J Diabetes Complications. 2022 03; 36(3):108127. PMID: 35067449.
      View in: PubMed
    20. Bauer C, Piani F, Banks M, Ordo?ez FA, de Lucas-Collantes C, Oshima K, Schmidt EP, Zakharevich I, Segarra A, Martinez C, Roncal-Jimenez C, Satchell SC, Bjornstad P, Lucia MS, Blaine J, Thurman JM, Johnson RJ, Cara-Fuentes G. Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation. Kidney Int Rep. 2022 Apr; 7(4):797-809. PMID: 35497798.
      View in: PubMed
    21. Bjornstad P, Drews K, Zeitler PS. Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply. N Engl J Med. 2021 11 18; 385(21):2016. PMID: 34788520.
      View in: PubMed
    22. Piani F, Sasai F, Bjornstad P, Borghi C, Yoshimura A, Sanchez-Lozada LG, Roncal-Jimenez C, Garcia GE, Hernando AA, Fuentes GC, Rodriguez-Iturbe B, Lanaspa MA, Johnson RJ. Hyperuricemia and chronic kidney disease: to treat or not to treat. J Bras Nefrol. 2021 Oct-Dec; 43(4):572-579. PMID: 33704350.
      View in: PubMed
    23. Cherney DZI, Bjornstad P, Perkins BA, Rosenstock J, Neubacher D, Marquard J, Soleymanlou N. Kidney Effects of Empagliflozin in People with Type 1 Diabetes. Clin J Am Soc Nephrol. 2021 11; 16(11):1715-1719. PMID: 34535454.
      View in: PubMed
    24. Piani F, Melena I, Severn C, Chung LT, Vinovskis C, Cherney D, Pyle L, Roncal-Jimenez CA, Lanaspa MA, Rewers A, van Raalte DH, Obeid W, Parikh C, Nelson RG, Pavkov ME, Nadeau KJ, Johnson RJ, Bjornstad P. Tubular injury in diabetic ketoacidosis: Results from the diabetic kidney alarm study. Pediatr Diabetes. 2021 11; 22(7):1031-1039. PMID: 34435718.
      View in: PubMed
    25. Bjornstad P, Drews KL, Caprio S, Gubitosi-Klug R, Nathan DM, Tesfaldet B, Tryggestad J, White NH, Zeitler P. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 07 29; 385(5):416-426. PMID: 34320286.
      View in: PubMed
    26. Bjornstad P, Greasley PJ, Wheeler DC, Chertow GM, Langkilde AM, Heerspink HJL, Van Raalte DH. The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure. J Card Fail. 2021 12; 27(12):1447-1455. PMID: 34289398.
      View in: PubMed
    27. Saulnier PJ, Looker HC, Mauer M, Najafian B, Gand E, Ragot S, Nelson RG, Bjornstad P. Intraglomerular Dysfunction Predicts Kidney Failure in Type 2 Diabetes. Diabetes. 2021 10; 70(10):2344-2352. PMID: 34257069.
      View in: PubMed
    28. Tommerdahl KL, Nadeau KJ, Bjornstad P. Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists. Adv Chronic Kidney Dis. 2021 07; 28(4):337-346. PMID: 34922690.
      View in: PubMed
    29. Bohling R, Grafals M, Moreau K, You Z, Tommerdahl KL, Bjornstad P, Stenson EK, Andrews E, Ramirez-Renteria L, Kendrick J. A Pilot Study of the Safety and Efficacy of Alkali Therapy on Vascular Function in Kidney Transplant Recipients. Kidney Int Rep. 2021 Sep; 6(9):2323-2330. PMID: 34514193.
      View in: PubMed
    30. Nakagawa T, Sanchez-Lozada LG, Andres-Hernando A, Kojima H, Kasahara M, Rodriguez-Iturbe B, Bjornstad P, Lanaspa MA, Johnson RJ. Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease. Front Immunol. 2021; 12:694457. PMID: 34220855.
      View in: PubMed
    31. Piani F, Reinicke T, Borghi C, Tommerdahl KL, Cara-Fuentes G, Johnson RJ, Bjornstad P. Acute Kidney Injury in Pediatric Diabetic Kidney Disease. Front Pediatr. 2021; 9:668033. PMID: 34211943.
      View in: PubMed
    32. van Velzen DM, Smits MM, van Bommel EJM, Muskiet MHA, Tonneijck L, Kramer MHH, Joles JA, den Heijer M, Nokoff N, Bjornstad P, van Raalte DH. Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function. Am J Physiol Renal Physiol. 2021 06 01; 320(6):F1152-F1158. PMID: 33900855.
      View in: PubMed
    33. Tommerdahl KL, Shapiro ALB, Nehus EJ, Bjornstad P. Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates. Pediatr Nephrol. 2022 01; 37(1):79-93. PMID: 33852054.
      View in: PubMed
    34. van Raalte DH, Bjornstad P, Heerspink HJL, Persson F, Cherney DZI. Importance of standardizing renal outcomes in clinical trials: illustration by recent sodium glucose cotransporter 2 inhibitor studies. Kidney Int. 2021 03; 99(3):768-770. PMID: 33637205.
      View in: PubMed
    35. Melena I, Bjornstad P, Sch?fer M, Hunter KS, Barker AJ, Baumgartner A, Chung L, Wiromrat P, Truong U, Reusch JEB, Nadeau KJ. Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study. J Diabetes Complications. 2021 05; 35(5):107883. PMID: 33712333.
      View in: PubMed
    36. Ambinathan JPN, Sridhar VS, Lytvyn Y, Lovblom LE, Liu H, Bjornstad P, Perkins BA, Lovshin JA, Cherney DZI. Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease. J Diabetes Complications. 2021 05; 35(5):107880. PMID: 33678512.
      View in: PubMed
    37. Andres-Hernando A, Jensen TJ, Kuwabara M, Orlicky DJ, Cicerchi C, Li N, Roncal-Jimenez CA, Garcia GE, Ishimoto T, Maclean PS, Bjornstad P, Sanchez-Lozada LG, Kanbay M, Nakagawa T, Johnson RJ, Lanaspa MA. Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. JCI Insight. 2021 01 11; 6(1). PMID: 33320834.
      View in: PubMed
    38. Tommerdahl KL, Baumgartner K, Sch?fer M, Bjornstad P, Melena I, Hegemann S, Baumgartner AD, Pyle L, Cree-Green M, Truong U, Browne L, Regensteiner JG, Reusch JEB, Nadeau KJ. Impact of Obesity on Measures of Cardiovascular and Kidney Health in Youth With Type 1 Diabetes as Compared With Youth With Type 2 Diabetes. Diabetes Care. 2021 03; 44(3):795-803. PMID: 33402367.
      View in: PubMed
    39. Scholtes RA, van Baar MJB, Kok MD, Bjornstad P, Cherney DZI, Joles JA, van Raalte DH. Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors. Nephrology (Carlton). 2021 May; 26(5):377-390. PMID: 33283420.
      View in: PubMed
    40. Piani F, Melena I, Tommerdahl KL, Nokoff N, Nelson RG, Pavkov ME, van Raalte DH, Cherney DZ, Johnson RJ, Nadeau KJ, Bjornstad P. Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications. J Diabetes Complications. 2021 04; 35(4):107841. PMID: 33423908.
      View in: PubMed
    41. Tommerdahl KL, Bjornstad P, Kendrick J, Cree-Green M, Baumgartner AD, Pyle L, Reusch JEB, Nadeau KJ. Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes. Diabetes Obes Metab. 2021 03; 23(3):844-849. PMID: 33236509.
      View in: PubMed
    42. Derderian SC, Patten L, Kaizer AM, Moore JM, Ogle S, Jenkins TM, Michalsky MP, Mitchell JE, Bjornstad P, Dixon JB, Inge TH. Influence of Weight Loss on Obesity-Associated Complications After Metabolic and Bariatric Surgery in Adolescents. Obesity (Silver Spring). 2020 12; 28(12):2397-2404. PMID: 33230961.
      View in: PubMed
    43. Piani F, Reinicke T, Lytvyn Y, Melena I, Lovblom LE, Lai V, Tse J, Cham L, Orszag A, Perkins BA, Cherney DZI, Bjornstad P. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. J Diabetes Complications. 2021 03; 35(3):107807. PMID: 33288413.
      View in: PubMed
    44. Ryder JR, Xu P, Nadeau KJ, Kelsey MM, Xie C, Jenkins T, Inge TH, Bjornstad P. Effect of surgical versus medical therapy on estimated cardiovascular event risk among adolescents with type 2 diabetes and severe obesity. Surg Obes Relat Dis. 2021 Jan; 17(1):23-33. PMID: 33071178.
      View in: PubMed
    45. Seegmiller JC, Wolfe BJ, Albtoush N, Melena I, Gross SP, Vinovskis C, Ix JH, Bjornstad P. Tubular Secretion Markers, Glomerular Filtration Rate, Effective Renal Plasma Flow, and Filtration Fraction in Healthy Adolescents. Kidney Med. 2020 Sep-Oct; 2(5):670-672. PMID: 33089146.
      View in: PubMed
    46. Vinovskis C, Li LP, Prasad P, Tommerdahl K, Pyle L, Nelson RG, Pavkov ME, van Raalte D, Rewers M, Pragnell M, Mahmud FH, Cherney DZ, Johnson RJ, Nadeau KJ, Bjornstad P. Relative Hypoxia and Early Diabetic Kidney Disease in Type 1 Diabetes. Diabetes. 2020 12; 69(12):2700-2708. PMID: 32737116.
      View in: PubMed
    47. Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, Borghi C, Piani F, Cara-Fuentes G, Bjornstad P, Lanaspa MA, Johnson RJ. Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020 07 18; 33(7):583-594. PMID: 32179896.
      View in: PubMed
    48. Sch?fer M, Bjornstad P, Frank BS, Baumgartner A, Truong U, Enge D, von Alvensleben JC, Mitchell MB, Ivy DD, Barker AJ, Reusch JEB, Nadeau KJ. Frequency of Reduced Left Ventricular Contractile Efficiency and Discoordinated Myocardial Relaxation in Patients Aged 16 to 21 Years With Type 1 Diabetes Mellitus (from the Emerald Study). Am J Cardiol. 2020 08 01; 128:45-53. PMID: 32650923.
      View in: PubMed
    49. Phadke G, Kaushal A, Tolan DR, Hahn K, Jensen T, Bjornstad P, Roncal-Jimenez C, Hernando AA, Lanaspa MA, Alexander MP, Kukla A, Johnson RJ. Osmotic Nephrosis and Acute Kidney Injury Associated With SGLT2 Inhibitor Use: A Case Report. Am J Kidney Dis. 2020 07; 76(1):144-147. PMID: 32387022.
      View in: PubMed
    50. Mosterd CM, Bjornstad P, van Raalte DH. Nephroprotective effects of GLP-1 receptor agonists: where do we stand? J Nephrol. 2020 Oct; 33(5):965-975. PMID: 32356231.
      View in: PubMed
    51. Hesp AC, Schaub JA, Prasad PV, Vallon V, Laverman GD, Bjornstad P, van Raalte DH. The role of renal hypoxia in the pathogenesis of?diabetic kidney disease: a promising target for?newer renoprotective agents including SGLT2?inhibitors? Kidney Int. 2020 09; 98(3):579-589. PMID: 32739206.
      View in: PubMed
    52. Lytvyn Y, Bjornstad P, van Raalte DH, Heerspink HL, Cherney DZI. The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications. Endocr Rev. 2020 04 01; 41(2). PMID: 31633153.
      View in: PubMed
    53. Kuwabara M, Hisatome I, Niwa K, Bjornstad P, Roncal-Jimenez CA, Andres-Hernando A, Kanbay M, Johnson RJ, Lanaspa MA. The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study. J Clin Med. 2020 Mar 30; 9(4). PMID: 32235468.
      View in: PubMed
    54. Bjornstad P, Nehus E, Jenkins T, Mitsnefes M, Moxey-Mims M, Dixon JB, Inge TH. Five-year kidney outcomes of bariatric surgery differ in severely obese adolescents and adults with and without type 2 diabetes. Kidney Int. 2020 05; 97(5):995-1005. PMID: 32229096.
      View in: PubMed
    55. Bjornstad P, Nehus E, van Raalte D. Bariatric surgery and kidney disease outcomes in severely obese youth. Semin Pediatr Surg. 2020 Feb; 29(1):150883. PMID: 32238288.
      View in: PubMed
    56. Bjornstad P, Nelson RG, Pavkov ME. Do sodium-glucose cotransporter-2 inhibitors affect renal hemodynamics by different mechanisms in type 1 and type 2 diabetes? Kidney Int. 2020 01; 97(1):31-33. PMID: 31901353.
      View in: PubMed
    57. van Raalte DH, Bjornstad P. Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes. Nephrol Dial Transplant. 2020 01 01; 35(Suppl 1):i24-i32. PMID: 32003832.
      View in: PubMed
    58. Joosten LAB, Crisan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020 02; 16(2):75-86. PMID: 31822862.
      View in: PubMed
    59. Lytvyn Y, Bjornstad P, Katz A, Singh SK, Godoy LC, Chung LT, Vinovskis CL, Pyle L, Roussel R, Perkins BA, Cherney D. SGLT2 inhibition increases serum copeptin in young adults with type 1 diabetes. Diabetes Metab. 2020 06; 46(3):203-209. PMID: 31816431.
      View in: PubMed
    60. Bjornstad P, Hughan K, Kelsey MM, Shah AS, Lynch J, Nehus E, Mitsnefes M, Jenkins T, Xu P, Xie C, Inge T, Nadeau K. Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes. Diabetes Care. 2020 01; 43(1):187-195. PMID: 31685489.
      View in: PubMed
    61. Sekercioglu N, Lovblom LE, Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Farooqi MA, Orszag A, Lai V, Tse J, Cham L, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes. Ren Fail. 2019 Nov; 41(1):427-433. PMID: 31162987.
      View in: PubMed
    62. van Bommel EJM, Ruiter D, Muskiet MHA, van Baar MJB, Kramer MHH, Nieuwdorp M, Joles JA, Bjornstad P, van Raalte DH. Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function. Diabetes Care. 2020 01; 43(1):228-234. PMID: 31662305.
      View in: PubMed
    63. Vigers T, Chan CL, Snell-Bergeon J, Bjornstad P, Zeitler PS, Forlenza G, Pyle L. cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data. PLoS One. 2019; 14(10):e0216851. PMID: 31603912.
      View in: PubMed
    64. Potier L, Roussel R, Marre M, Bjornstad P, Cherney DZ, El Boustany R, Fumeron F, Venteclef N, Gautier JF, Hadjadj S, Mohammedi K, Velho G. Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes. Diabetes Care. 2019 12; 42(12):2290-2297. PMID: 31582427.
      View in: PubMed
    65. Srinivasan Sridhar V, Ambinathan JPN, Kretzler M, Pyle LL, Bjornstad P, Eddy S, Cherney DZ, Reich HN. Renal SGLT mRNA expression in human health and disease: a study in two cohorts. Am J Physiol Renal Physiol. 2019 11 01; 317(5):F1224-F1230. PMID: 31545924.
      View in: PubMed
    66. Al-Ozairi E, Rivard CJ, Sanchez Lozada LG, Lanaspa MA, Bjornstad P, Al Salem D, Alhubail A, Megahed A, Kuwabara M, Johnson RJ, Asad RA. Fructose tolerance test in obese people with and without type 2 diabetes. J Diabetes. 2020 Mar; 12(3):197-204. PMID: 31472036.
      View in: PubMed
    67. Wiromrat P, Bjornstad P, Vinovskis C, Chung LT, Roncal C, Pyle L, Lanaspa MA, Johnson RJ, Cherney DZ, Reznick-Lipina TK, Bishop F, Maahs DM, Wadwa RP. Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes. Pediatr Diabetes. 2019 12; 20(8):1110-1117. PMID: 31433534.
      View in: PubMed
    68. Mansour SG, Martin TG, Obeid W, Pata RW, Myrick KM, Kukova L, Jia Y, Bjornstad P, El-Khoury JM, Parikh CR. The Role of Volume Regulation and Thermoregulation in AKI during Marathon Running. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1297-1305. PMID: 31413064.
      View in: PubMed
    69. van Raalte DH, Bjornstad P, Persson F, Powell DR, de Cassia Castro R, Wang PS, Liu M, Heerspink HJL, Cherney D. The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes. Diabetes Care. 2019 10; 42(10):1921-1929. PMID: 31371432.
      View in: PubMed
    70. Wiromrat P, Bjornstad P, Roncal C, Pyle L, Johnson RJ, Cherney DZ, Lipina T, Bishop F, Maahs DM, Wadwa RP. Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes. J Diabetes Complications. 2019 09; 33(9):648-650. PMID: 31253490.
      View in: PubMed
    71. Bjornstad P, Lovshin JA, Lytvyn Y, Lovblom LE, Scarr D, Boulet G, Farooqi MA, Orszag A, Bai JW, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report. J Diabetes Complications. 2019 08; 33(8):547-549. PMID: 31186164.
      View in: PubMed
    72. Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 06; 42(6):1120-1128. PMID: 30967435.
      View in: PubMed
    73. Scholtes RA, van Baar MJB, Lytvyn Y, Bjornstad P, Nieuwdorp M, Cherney DZI, van Raalte DH. Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes Obes Metab. 2019 04; 21 Suppl 2:24-33. PMID: 30843294.
      View in: PubMed
    74. Lytvyn Y, Bjornstad P, Lovshin JA, Singh SK, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI. Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes. Diabetes Obes Metab. 2019 06; 21(6):1388-1398. PMID: 30761725.
      View in: PubMed
    75. Wiromrat P, Bjornstad P, Roncal C, Cree-Green M, Baumgartner A, Coe G, Reyes YG, Sch?fer M, Truong U, Pyle L, Johnson RJ, Nadeau KJ. Serum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD study. J Diabetes Complications. 2019 06; 33(6):434-436. PMID: 31003921.
      View in: PubMed
    76. Lytvyn Y, Bjornstad P, Lovshin JA, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes. Am J Kidney Dis. 2019 06; 73(6):786-796. PMID: 30799029.
      View in: PubMed
    77. Scarr D, Bjornstad P, Lovblom LE, Lovshin JA, Boulet G, Lytvyn Y, Farooqi MA, Lai V, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA. Estimating GFR by Serum Creatinine, Cystatin C, and ?2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes. Kidney Int Rep. 2019 Jun; 4(6):786-796. PMID: 31194091.
      View in: PubMed
    78. Bjornstad P, Sch?fer M, Truong U, Cree-Green M, Pyle L, Baumgartner A, Garcia Reyes Y, Maniatis A, Nayak S, Wadwa RP, Browne LP, Reusch JEB, Nadeau KJ. Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus. Circulation. 2018 12 18; 138(25):2895-2907. PMID: 30566007.
      View in: PubMed
    79. Lovshin JA, Lytvyn Y, Lovblom LE, Katz A, Boulet G, Bjornstad P, Lai V, Cham L, Tse J, Orszag A, Keenan HA, Paul N, Bril V, Wong DT, McReelis KD, Brent MH, Perkins BA, Cherney DZI. Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes. Diabetes Care. 2019 02; 42(2):273-280. PMID: 30523033.
      View in: PubMed
    80. Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZI, Wong R, Rewers MJ, Snell-Bergeon JK. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study. Diabetes Care. 2019 02; 42(2):297-302. PMID: 30482755.
      View in: PubMed
    81. Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes. Diabetes Obes Metab. 2019 03; 21(3):575-583. PMID: 30311395.
      View in: PubMed
    82. Bjornstad P, Eckel RH. Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review. Curr Diab Rep. 2018 10 17; 18(12):127. PMID: 30328521.
      View in: PubMed
    83. Lovshin JA, Bjornstad P, Lovblom LE, Bai JW, Lytvyn Y, Boulet G, Farooqi MA, Santiago S, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2570-2578. PMID: 30275283.
      View in: PubMed
    84. Le?n Jim?nez D, Cherney DZI, Bjornstad P, Castilla-Guerra L, Miramontes Gonz?lez JP. Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1406-F1415. PMID: 30066584.
      View in: PubMed
    85. Bjornstad P, Pyle L, Cherney DZI, Johnson RJ, Sippl R, Wong R, Rewers M, Snell-Bergeon JK. Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study. Nephrol Dial Transplant. 2018 07 01; 33(7):1189-1196. PMID: 28992280.
      View in: PubMed
    86. Bjornstad P, Laffel L, Tamborlane WV, Simons G, Hantel S, von Eynatten M, George J, Marquard J, Cherney DZI. Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes. Diabetes Care. 2018 08; 41(8):e129-e130. PMID: 29941496.
      View in: PubMed
    87. Kuwabara M, Hisatome I, Roncal-Jimenez CA, Niwa K, Andres-Hernando A, Jensen T, Bjornstad P, Milagres T, Cicerchi C, Song Z, Garcia G, S?nchez-Lozada LG, Ohno M, Lanaspa MA, Johnson RJ. Correction: Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study. PLoS One. 2018; 13(5):e0197941. PMID: 29772014.
      View in: PubMed
    88. Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI. Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials". Circulation. 2018 05 01; 137(18):1984-1985. PMID: 29712705.
      View in: PubMed
    89. Roncal-Jimenez CA, Sato Y, Milagres T, Andres Hernando A, Garc?a G, Bjornstad P, Dawson JB, Sorensen C, Newman L, Krisher L, Madero M, Glaser J, G?rc?a-Trabanino R, Romero EJ, Song Z, Jensen T, Kuwabara M, Rodriguez-Iturbe B, Sanchez-Lozada LG, Lanaspa MA, Johnson RJ. Experimental heat stress nephropathy and liver injury are improved by allopurinol. Am J Physiol Renal Physiol. 2018 09 01; 315(3):F726-F733. PMID: 29667911.
      View in: PubMed
    90. Bjornstad P, Maahs DM, Roncal CA, Snell-Bergeon JK, Shah VN, Milagres T, Ellis SL, Hatch M, Chung LT, Rewers MJ, Garg S, Cherney DZ, Pyle L, Nadeau KJ, Johnson RJ. Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes. Diabetes Obes Metab. 2018 07; 20(7):1776-1780. PMID: 29498467.
      View in: PubMed
    91. Bjornstad P, Cherney DZ. Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease. Curr Diab Rep. 2018 03 19; 18(5):22. PMID: 29557063.
      View in: PubMed
    92. Jensen T, Bjornstad P, Johnson RJ, Sippl R, Rewers M, Snell-Bergeon JK. Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes. 2019 Feb; 43(1):34-39. PMID: 30026043.
      View in: PubMed
    93. Bjornstad P, Donaghue KC, Maahs DM. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol. 2018 10; 6(10):809-820. PMID: 29475800.
      View in: PubMed
    94. Tonneijck L, Muskiet MHA, Smits MM, Bjornstad P, Kramer MHH, Diamant M, Hoorn EJ, Joles JA, van Raalte DH. Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials. Diabetes Obes Metab. 2018 05; 20(5):1235-1245. PMID: 29341461.
      View in: PubMed
    95. Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Lovblom LE, Alhuzaim ON, Farooqi MA, Lai V, Tse J, Cham L, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes. Diabetes Care. 2018 04; 41(4):831-839. PMID: 29437821.
      View in: PubMed
    96. Lovshin JA, Boulet G, Lytvyn Y, Lovblom LE, Bjornstad P, Farooqi MA, Lai V, Cham L, Tse J, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZ. Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes. JCI Insight. 2018 01 11; 3(1). PMID: 29321380.
      View in: PubMed
    97. Gidding SS, Bacha F, Bjornstad P, Levitt Katz LE, Levitsky LL, Lynch J, Tryggestad JB, Weinstock RS, El Ghormli L, Lima JAC. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr. 2018 01; 192:86-92.e5. PMID: 29246363.
      View in: PubMed
    98. Bjornstad P, Karger AB, Maahs DM. Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots. Adv Chronic Kidney Dis. 2018 01; 25(1):76-83. PMID: 29499891.
      View in: PubMed
    99. Lovshin JA, ?krtic M, Bjornstad P, Moineddin R, Daneman D, Dunger D, Reich HN, Mahmud F, Scholey J, Cherney DZI, Sochett E. Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitus. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F667-F674. PMID: 29357443.
      View in: PubMed
    100. Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T, Garcia G, Rodriguez-Iturbe B, Ohno M, Lanaspa MA, Johnson RJ. Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study. Hypertension. 2018 01; 71(1):78-86. PMID: 29203632.
      View in: PubMed
    101. Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74. PMID: 29157731.
      View in: PubMed
    102. Rajasekeran H, Reich HN, Hladunewich MA, Cattran D, Lovshin JA, Lytvyn Y, Bjornstad P, Lai V, Tse J, Cham L, Majumder S, Bowskill BB, Kabir MG, Advani SL, Gibson IW, Sood MM, Advani A, Cherney DZI. Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study. Am J Physiol Renal Physiol. 2018 03 01; 314(3):F412-F422. PMID: 29141939.
      View in: PubMed
    103. Bjornstad P, Cree-Green M, Baumgartner A, Coe G, Reyes YG, Sch?fer M, Pyle L, Regensteiner JG, Reusch JE, Nadeau KJ. Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MEtformin on CardiovasculaR Function in AdoLescents with Type 1 Diabetes (EMERALD) Studies. Pediatr Diabetes. 2018 05; 19(3):436-442. PMID: 29082640.
      View in: PubMed
    104. Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI. Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials. Circulation. 2017 Oct 24; 136(17):1643-1658. PMID: 29061576.
      View in: PubMed
    105. Kuwabara M, Kuwabara R, Hisatome I, Niwa K, Roncal-Jimenez CA, Bjornstad P, Andres-Hernando A, Sato Y, Jensen T, Garcia G, Ohno M, Hill JO, Lanaspa MA, Johnson RJ. "Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study. Obesity (Silver Spring). 2017 11; 25(11):1997-2008. PMID: 28922565.
      View in: PubMed
    106. Bjornstad P, Costacou T, Miller RG, Maahs DM, Rewers MJ, Orchard TJ, Snell-Bergeon JK. Predictors of early renal function decline in adults with Type?1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies. Diabet Med. 2017 11; 34(11):1532-1540. PMID: 28734104.
      View in: PubMed
    107. Bjornstad P, Cherney DZI. Kidney Function Can Predict Pregnancy Outcomes. Clin J Am Soc Nephrol. 2017 07 07; 12(7):1029-1031. PMID: 28611077.
      View in: PubMed
    108. Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T, Garcia G, Ohno M, Lanaspa MA, Johnson RJ. Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study. Hypertension. 2017 06; 69(6):1036-1044. PMID: 28396536.
      View in: PubMed
    109. Bjornstad P, Cree-Green M, Baumgartner A, Coe G, Reyes YG, Schafer M, Pyle L, Regensteiner JG, Reusch JEB, Nadeau KJ. Leptin is associated with cardiopulmonary fitness independent of body-mass index and insulin sensitivity in adolescents with type 1 diabetes: a brief report from the EMERALD study. J Diabetes Complications. 2017 May; 31(5):850-853. PMID: 28336216.
      View in: PubMed
    110. Kuwabara M, Bjornstad P, Hisatome I, Niwa K, Roncal-Jimenez CA, Andres-Hernando A, Jensen T, Milagres T, Sato Y, Garcia G, Ohno M, Lanaspa MA, Johnson RJ. Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function. Am J Nephrol. 2017; 45(4):330-337. PMID: 28285309.
      View in: PubMed
    111. Kuwabara M, Hisatome I, Roncal-Jimenez CA, Niwa K, Andres-Hernando A, Jensen T, Bjornstad P, Milagres T, Cicerchi C, Song Z, Garcia G, S?nchez-Lozada LG, Ohno M, Lanaspa MA, Johnson RJ. Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study. PLoS One. 2017; 12(1):e0169137. PMID: 28081152.
      View in: PubMed
    112. ?krtic M, Lytvyn Y, Bjornstad P, Reich HN, Scholey JW, Yip P, Sochett EB, Perkins B, Cherney DZ. Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes. Am J Physiol Renal Physiol. 2017 04 01; 312(4):F599-F606. PMID: 28031170.
      View in: PubMed
    113. Bjornstad P, Johnson RJ, Snell-Bergeon JK, Pyle L, Davis A, Foster N, Cherney DZ, Maahs DM. Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank. J Diabetes Complications. 2017 Feb; 31(2):387-389. PMID: 27979439.
      View in: PubMed
    114. Shah P, Bjornstad P, Johnson RJ. Hyperuricemia as a potential risk factor for type 2 diabetes and diabetic nephropathy. J Bras Nefrol. 2016 Dec; 38(4):386-387. PMID: 28001176.
      View in: PubMed
    115. Bjornstad P, ?krtic M, Lytvyn Y, Maahs DM, Johnson RJ, Cherney DZ. The Gomez' equations and renal hemodynamic function in kidney disease research. Am J Physiol Renal Physiol. 2016 11; 311(5):F967-F975. PMID: 27605583.
      View in: PubMed
    116. Bjornstad P, Pyle L, Kinney GL, Rewers M, Johnson RJ, Maahs DM, Snell-Bergeon JK. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. J Diabetes Complications. 2017 Feb; 31(2):369-374. PMID: 27368123.
      View in: PubMed
    117. Lytvyn Y, Bjornstad P, Pun N, Cherney DZ. New and old agents in the management of diabetic nephropathy. Curr Opin Nephrol Hypertens. 2016 May; 25(3):232-9. PMID: 26890303.
      View in: PubMed
    118. Bjornstad P, Maahs DM, Jensen T, Lanaspa MA, Johnson RJ, Rewers M, Snell-Bergeon JK. Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes. J Diabetes Complications. 2016 08; 30(6):1093-6. PMID: 27141815.
      View in: PubMed
    119. Bjornstad P, Truong U, Pyle L, Dorosz JL, Cree-Green M, Baumgartner A, Coe G, Regensteiner JG, Reusch JE, Nadeau KJ. Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) Study. J Diabetes Complications. 2016 08; 30(6):1103-10. PMID: 27133451.
      View in: PubMed
    120. Bjornstad P, Truong U, Dorosz JL, Cree-Green M, Baumgartner A, Coe G, Pyle L, Regensteiner JG, Reusch JE, Nadeau KJ. Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes. J Am Heart Assoc. 2016 Mar 18; 5(3):e002804. PMID: 26994128.
      View in: PubMed
    121. Bjornstad P, Maahs DM, Duca LM, Pyle L, Rewers M, Johnson RJ, Snell-Bergeon JK. Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study. J Diabetes Complications. 2016 May-Jun; 30(4):586-90. PMID: 26936306.
      View in: PubMed
    122. Bjornstad P, Cherney DZ, Maahs DM, Nadeau KJ. Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies. Curr Diab Rep. 2016 Feb; 16(2):11. PMID: 26803647.
      View in: PubMed
    123. Bjornstad P, Roncal C, Milagres T, Pyle L, Lanaspa MA, Bishop FK, Snell-Bergeon JK, Johnson RJ, Wadwa RP, Maahs DM. Hyperfiltration and uricosuria in adolescents with type 1 diabetes. Pediatr Nephrol. 2016 May; 31(5):787-93. PMID: 26701836.
      View in: PubMed
    124. Duca LM, Maahs DM, Schauer IE, Bergman BC, Nadeau KJ, Bjornstad P, Rewers M, Snell-Bergeon JK. Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes. J Clin Endocrinol Metab. 2016 Feb; 101(2):686-95. PMID: 26672636.
      View in: PubMed
    125. Bjornstad P, Cherney DZ, Maahs DM. Update on Estimation of Kidney Function in Diabetic Kidney Disease. Curr Diab Rep. 2015 Sep; 15(9):57. PMID: 26188736.
      View in: PubMed
    126. Bjornstad P, Eckel RH, Pyle L, Rewers M, Maahs DM, Snell-Bergeon JK. Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus. Am J Cardiol. 2015 Oct 01; 116(7):1057-62. PMID: 26251001.
      View in: PubMed
    127. Bjornstad P, Lanaspa MA, Ishimoto T, Kosugi T, Kume S, Jalal D, Maahs DM, Snell-Bergeon JK, Johnson RJ, Nakagawa T. Fructose and uric acid in diabetic nephropathy. Diabetologia. 2015 Sep; 58(9):1993-2002. PMID: 26049401.
      View in: PubMed
    128. Bjornstad P, Cherney DZ, Snell-Bergeon JK, Pyle L, Rewers M, Johnson RJ, Maahs DM. Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes. Nephrol Dial Transplant. 2015 Oct; 30(10):1706-11. PMID: 26050268.
      View in: PubMed
    129. Bjornstad P, Cherney DZ, Maahs DM, Nadeau KJ. Fat Mass Is Associated With Cystatin C and Estimated Glomerular Filtration Rate in Adolescents With Type 1 Diabetes. J Ren Nutr. 2015 Sep; 25(5):454-5. PMID: 26028175.
      View in: PubMed
    130. Bjornstad P, Anderson PL, Maahs DM. Measuring glomerular filtration rate by iohexol clearance on filter paper is feasible in adolescents with type 1 diabetes in the ambulatory setting. Acta Diabetol. 2016 Apr; 53(2):331-3. PMID: 25959420.
      View in: PubMed
    131. Bjornstad P, Maahs DM. Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies. Curr Pediatr Rep. 2015 Jun 01; 3(2):177-186. PMID: 26425403.
      View in: PubMed
    132. Bjornstad P, Snell-Bergeon JK, Nadeau KJ, Maahs DM. Insulin sensitivity and complications in type 1 diabetes: New insights. World J Diabetes. 2015 Feb 15; 6(1):8-16. PMID: 25685274.
      View in: PubMed
    133. Bjornstad P, Pyle L, Nguyen N, Snell-Bergeon JK, Bishop FK, Wadwa RP, Maahs DM. Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes. Pediatr Diabetes. 2015 Feb; 16(1):22-30. PMID: 25604668.
      View in: PubMed
    134. Kelsey MM, Bjornstad P, McFann K, Nadeau K. Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes. Pediatr Diabetes. 2016 May; 17(3):184-90. PMID: 25611822.
      View in: PubMed
    135. Bjornstad P, Nguyen N, Reinick C, Maahs DM, Bishop FK, Clements SA, Snell-Bergeon JK, Lieberman R, Pyle L, Daniels SR, Paul Wadwa R. Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes. Acta Diabetol. 2015 Jun; 52(3):611-9. PMID: 25539881.
      View in: PubMed
    136. Bjornstad P, Cree-Green M, Baumgartner A, Maahs DM, Cherney DZ, Pyle L, Regensteiner JG, Reusch JE, Nadeau KJ. Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes. Diabetes Care. 2015 Jan; 38(1):126-31. PMID: 25414156.
      View in: PubMed
    137. Bjornstad P, Maahs DM, Johnson RJ, Rewers M, Snell-Bergeon JK. Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes. Diabet Med. 2015 Feb; 32(2):257-61. PMID: 25303233.
      View in: PubMed
    138. Bjornstad P, Maahs DM, Wadwa RP, Pyle L, Rewers M, Eckel RH, Snell-Bergeon JK. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. J Clin Lipidol. 2014 Nov-Dec; 8(6):576-583. PMID: 25499940.
      View in: PubMed
    139. Bjornstad P, Cherney D, Maahs DM. Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes. 2014 Aug; 21(4):279-86. PMID: 24983394.
      View in: PubMed
    140. Bjornstad P, Maahs DM, Cherney DZ, Cree-Green M, West A, Pyle L, Nadeau KJ. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes. Diabetes Care. 2014 Nov; 37(11):3033-9. PMID: 25071077.
      View in: PubMed
    141. Bjornstad P, Maahs DM, Rewers M, Johnson RJ, Snell-Bergeon JK. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. J Diabetes Complications. 2014 Nov-Dec; 28(6):762-6. PMID: 25270733.
      View in: PubMed
    142. Bjornstad P, Wadwa RP. Risks and benefits of statin use in young people with type 1 diabetes. Curr Diab Rep. 2014 Jul; 14(7):499. PMID: 24796934.
      View in: PubMed
    143. Bjornstad P, Maahs DM, Rivard CJ, Pyle L, Rewers M, Johnson RJ, Snell-Bergeon JK. Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol. 2014 Oct; 51(5):783-91. PMID: 24929955.
      View in: PubMed
    144. Bjornstad P, McQueen RB, Snell-Bergeon JK, Cherney D, Pyle L, Perkins B, Rewers M, Maahs DM. Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes? PLoS One. 2014; 9(4):e96264. PMID: 24781861.
      View in: PubMed
    145. Bjornstad P, Paul Wadwa R, Sirota JC, Snell-Bergeon JK, McFann K, Rewers M, Rivard CJ, Jalal D, Chonchol MB, Johnson RJ, Maahs DM. Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens (Greenwich). 2014 Apr; 16(4):283-8. PMID: 24667019.
      View in: PubMed
    146. Kelsey MM, Zaepfel A, Bjornstad P, Nadeau KJ. Age-related consequences of childhood obesity. Gerontology. 2014; 60(3):222-8. PMID: 24434909.
      View in: PubMed
    147. Bjornstad P, Snell-Bergeon JK, McFann K, Wadwa RP, Rewers M, Rivard CJ, Jalal D, Chonchol MB, Johnson RJ, Maahs DM. Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes. J Diabetes Complications. 2014 May-Jun; 28(3):298-304. PMID: 24461546.
      View in: PubMed
    Bjornstad's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (340) concept(s)
    _
    Co-Authors Expand Description
    See all (44) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)